SUMMARY
Albert N. Attia, M.D., is a board-certified radiation oncologist that treats people with prostate cancers, bladder cancers, kidney cancers as well as gynecological cancers. Before joining Mayo Clinic, Dr. Attia was an associate professor and residency program director at Vanderbilt University Medical Center.
Dr. Attia's research interests focus on improving cancer outcomes in people with prostate cancer by studying effects of radiotherapy in combination with new medicines and radiopharmaceuticals. As an educator, Dr. Attia participates in research to improve the educational experience for radiation oncology residents.
Focus areas
- Utilization of stereotactic body radiotherapy for treatment of oligometastatic prostate cancer.
- Studying the role of radiopharmaceuticals and external beam radiotherapy to improve therapeutic index for individuals with prostate cancer.
- Improving treatment delivery of external beam radiotherapy for people with prostate cancer.
- Identifying ways artificial intelligence can be used to improve resident education in radiation oncology.
Significance to patient care
Dr. Attia's research efforts, in treatment delivery and efficacy, improve care for people with prostate cancer. Moreover, education research improves the knowledge base of graduating residents. This education should in turn result in better-trained physicians, which may then result in better outcomes for individuals.
Professional highlights
- Vice president and president elect, Association for Directors of Radiation Oncology Programs, 2023.
- Education Science Career Development Award, Office of Applied Scholarship and Education Science, Mayo Clinic, 2022.